Notice of GM

25 August 2026
Seed Capital Solutions plc
("Seed" or the "Company")
Notice of GM
Form of Proxy
Seed Capital Solutions plc announces that as a direct result of the aborted acquisition of 4D Medica SA ("4DM") ("Transaction"), the Company requires new funding by way of the issuance of new ordinary shares in the Company ("Shares").
The Company does not however, currently have the authority to issue sufficient Shares to satisfy its short-term working capital requirements and settle its professional creditors incurred in respect of the Transaction.
Notice is given that a General Meeting ("GM") of the members of the Company will be held at the office of Axis Capital Markets Ltd, 73 Watling St, London, EC4M 9BJ at 1000 hrs (BST) on 17 September 2026. The purpose of the GM is to seek approval by shareholders of the authorities required to enable the Company to raise the necessary funding.
Background
As previously announced, the Company had accrued adviser costs in respect of the proposed acquisition of 4DM which was terminated on 10 July 2026 and which the Company had expected to be settled from an associated fundraising.
The Company has agreed to settle up to £125,000 of these professional creditors through an issue of new ordinary shares, and a further £50,000 in cash ("Creditor Settlement").
The Board is therefore convening a shareholder GM to seek approval for the authorities necessary to issue the new Shares to creditors and to undertake an equity fundraising.
Subject to shareholder approval, the Board intends to raise sufficient capital to enable the Company to satisfy its ongoing obligations, estimated to be no more than £85,000 for the next 12 months, settle certain professional liabilities as above and to provide some initial capital to pursue suitable acquisition and investment opportunities ("Fundraising").
The Company's broker has indicated its support for the Fundraising, subject to the relevant shareholder approvals being obtained.
Resolutions
The Resolutions to be proposed at the GM are therefore as follows:
Resolution 1 is an ordinary resolution which seeks to authorise the Directors, pursuant to section 551 of the Companies Act 2006, to allot shares and other relevant securities up to the limits set out in the Notice of General Meeting.
Resolution 2 is a special resolution which seeks to permit the Directors, within the limits set out in the Notice of GM, to allot equity securities for cash without first offering those securities to existing shareholders in proportion to their existing holdings. The Directors consider this authority necessary to provide the flexibility required to undertake the proposed fundraising and address the Company's immediate funding requirements.
Suspension
On completion of the Creditor Settlement and Fundraising following the GM, the Company will subsequently make a request to the FCA to lift the temporary suspension of its listing on the Official List of the FCA of its shares.
Financial Results calendar
As previously announced, following the change of the accounting reference date from 30 June to 31 December, as announced on 29 June 2026, in accordance with UKLR6.4.16 the Company will prepare and publish a second interim report in respect of the six-months ending 30 June 2026, to be published on or before 30 September 2026.
Form of Proxy
A copy of the Notice of GM and Form of Proxy is being posted to Shareholders today and is available on the Company's website at https://seedcapitalsolutionsplc.com/wp-content/uploads/2026/08/260825-SCS-GM-Notice-FINAL.pdf
ENDS
FOR FURTHER INFORMATION, PLEASE CONTACT:
Seed Capital Solutions plc
Chairman Damion Greef
Website: https://seedcapitalsolutionsplc.com/ Tel: +44 (0)1535 647 479
Brand Communications
Public & Investor Relations
Alan Green Tel: +44 (0) 7976 431608
ABOUT SEED CAPITAL SOLUTIONS PLC
Seed Capital Solutions Plc (LON: SCSP) has been formed for the purpose of acquiring a business or businesses operating in market sectors that can display strong ESG credentials, thereby benefitting from the current trend of superior performance and increased investor appetite
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Proactive Investors is a publisher of financial news and information. No content in this record, or published on the Proactive Investors website (the "Site"), constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. No content is tailored to any specific person's needs, objectives, or financial situation.
Proactive Investors is not a registered investment adviser or broker-dealer and does not provide personalized investment advice. Nothing in this record constitutes investment advice or a recommendation to buy, hold, or sell any security. None of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value, or suitability of any particular security, portfolio, transaction, or investment strategy. Any decision to buy, sell, or hold a security should be made only after consulting an appropriately qualified, licensed financial adviser and reading all relevant offering documentation.
This record, and any record we publish by or on behalf of our clients, should not be construed as an offer or solicitation to buy or sell any product or security. Our content is independent financial journalism, produced in a neutral, objective style with full source attribution.
In accordance with the Federal Trade Commission's guidelines on material connections, Proactive Investors discloses the following: we may receive cash or, in some cases, equity compensation from companies whose news is distributed through our platform. This compensation is for news distribution and media services, not for editorial content or coverage decisions. Where Proactive Investors has a commercial relationship with a company covered in this record, that relationship is disclosed within the article. Any such relationship does not determine, influence, or shape the editorial content produced. Where we receive equity compensation, such securities are held independently by a third-party broker and sold at the broker's discretion.
The Site may contain opinions from time to time regarding securities mentioned in other products, including company-related products, and those opinions may differ from those obtained through another Proactive Investors product. Opinions and commentary reflect the views of the named author at the time of writing and are subject to change without notice.
Price and other data is supplied by sources believed to be reliable. Any calculations are made using such data. Neither the data nor the calculations are guaranteed by those sources, by Proactive Investors, by the information providers, or by any other person or entity, and may not be complete or accurate.
From time to time, reference may be made in our marketing materials to previously published articles or opinions. Such references may be selective, may reference only a portion of an article, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.
FOR OUR FULL DISCLAIMER CLICK HERE